Role of Antibiotics Post Tonsillectomy
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT03491085|
Recruitment Status : Not yet recruiting
First Posted : April 9, 2018
Last Update Posted : May 17, 2018
|Condition or disease||Intervention/treatment||Phase|
|Tonsillectomy||Drug: Amoxicillin/clavulanate||Phase 1 Phase 2|
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||200 participants|
|Intervention Model:||Crossover Assignment|
|Official Title:||Study Of The Antibiotic Role In Post Tonsillectomy Complications|
|Estimated Study Start Date :||May 15, 2018|
|Estimated Primary Completion Date :||January 15, 2020|
|Estimated Study Completion Date :||March 15, 2020|
|Active Comparator: tonsillictomy with antibiotics||
after tonsillectomy half of our patients will receive Amoxicillin /clavulanate for one week and the other half will not receive it.
|No Intervention: tonsillictomy Without Antibiotics|
- compare the morbidity after tonsillectomy between the group which receive antibiotics and the other group which not receive antibiotics [ Time Frame: 2 years ]A questionnaire will be given to the parents on discharge to fill in the type of post-tonsillectomy morbidity of main concern including: fever, secondary bleeding, number of days with throat pain and the number of days to resume normal diet, incidence of abdominal pain, nausea & vomiting.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03491085
|Contact: ahmed alhussaini, firstname.lastname@example.org|